echo '

Zydus Cadila receives final approval from USFDA


Zydus Cadila has received final approval from the USFDA to market Propafenone Hydrochloride ExtendedRelease Capsules USP, 225 mg, 325 mg, and 425 mg, company said in the release.

Cadila Healthcare was quoting at Rs 553.30, up Rs 1.05, or 0.19 percent on the BSE.

News Source:- Moneycontrol

For Enquiry Fill The Form

    *Note:- Please provide a valid Email Id to receive OTP from

    Facebook Iconfacebook like buttonYouTube IconTwitter Icontwitter follow button